Pharmaceutical Technology-09-01-2015

Pharmaceutical Technology

Lessons Learned from FDA Inspections of Foreign API Facilities

September 08, 2015

Features

2015 Supplement

3

A study of recent inspection observations allows for baseline trending and continuous improvement. (The opinions expressed in this article do not necessarily reflect FDA’s position on the matter being discussed.)

Certifying Excipient cGMPs

September 08, 2015

Features

2015 Supplement

3

As EU supplier risk assessment deadlines approach, a number of voluntary third-party auditing and certification options are available. Will more excipient suppliers, and drug manufacturers, use them?

PAT Paves the Way for Continuous Manufacturing

September 01, 2015

Features

2015 Supplement

3

Process analytical technology is crucial for understanding a pharmaceutical or biopharmaceutical process. Thorough process knowledge is needed to develop process control strategies and select process equipment configuration for continuous manufacturing.

Regulatory Considerations for Controlled Correspondence Related to Generic Drug Chemistry

September 01, 2015

Features

2015 Supplement

3

An analysis of controlled correspondence between generic-drug manufacturers and FDA reveals patterns in questions about specific drug chemistry topics and the response to information provided in FDA guidance documents.

The PharmTech/CPhI Connection

September 01, 2015

From The Editor

2015 Supplement

3

This special issue combines technical articles on leading pharma industry topics and a comprehensive preview of the upcoming CPhI Worldwide trade show

Pharmaceutical Technology, September 2015 APIs, Excipients, and Manufacturing Supplement (PDF)

September 01, 2015

Issue PDF

2015 Supplement

3

Click the title above to open the Pharmaceutical Technology September 2015 APIs, Excipients, and Manufacturing Supplement in an interactive PDF format.